102 related articles for article (PubMed ID: 30953449)
1. Retention in care and virological failure among adult HIV+ patients on second-line ART in Rwanda: a national representative study.
Nsanzimana S; Semakula M; Ndahindwa V; Remera E; Sebuhoro D; Uwizihiwe JP; Ford N; Tanner M; Kanters S; Mills EJ; Bucher HC
BMC Infect Dis; 2019 Apr; 19(1):312. PubMed ID: 30953449
[TBL] [Abstract][Full Text] [Related]
2. Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda.
Ssempijja V; Nakigozi G; Chang L; Gray R; Wawer M; Ndyanabo A; Kasule J; Serwadda D; Castelnuovo B; Hoog AV; Reynolds SJ
BMC Infect Dis; 2017 Aug; 17(1):582. PubMed ID: 28830382
[TBL] [Abstract][Full Text] [Related]
3. Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India.
Khan S; Das M; Andries A; Deshpande A; Mansoor H; Saranchuk P; Isaakidis P
Glob Health Action; 2014; 7():24861. PubMed ID: 25084835
[TBL] [Abstract][Full Text] [Related]
4. Defining a Cutoff for Atazanavir in Hair Samples Associated With Virological Failure Among Adolescents Failing Second-Line Antiretroviral Treatment.
Chawana TD; Gandhi M; Nathoo K; Ngara B; Louie A; Horng H; Katzenstein D; Metcalfe J; Nhachi CFB;
J Acquir Immune Defic Syndr; 2017 Sep; 76(1):55-59. PubMed ID: 28520618
[TBL] [Abstract][Full Text] [Related]
5. Brief Report: Ritonavir Concentrations in Hair Predict Virologic Outcomes in HIV-Infected Adolescents With Virologic Failure on Atazanavir-Based or Ritonavir-Based Second-Line Treatment.
Chawana TD; Nhachi CFB; Nathoo K; Ngara B; Okochi H; Louie A; Kuncze K; Katzenstein D; Metcalfe J; Gandhi M;
J Acquir Immune Defic Syndr; 2021 Oct; 88(2):181-185. PubMed ID: 34117162
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of second-line antiretroviral therapy among people living with HIV/AIDS in Asia: results from the TREAT Asia HIV observational database.
Boettiger DC; Nguyen VK; Durier N; Bui HV; Heng Sim BL; Azwa I; Law M; Ruxrungtham K
J Acquir Immune Defic Syndr; 2015 Feb; 68(2):186-95. PubMed ID: 25590271
[TBL] [Abstract][Full Text] [Related]
7. Expanded access to viral load testing and use of second line regimens in Haiti: time trends from 2010-2017.
Wang Y; Barnhart S; Francois K; Robin E; Kalou M; Perrin G; Hall L; Koama JB; Marinho E; Balan JG; Honoré JG; Puttkammer N
BMC Infect Dis; 2020 Apr; 20(1):283. PubMed ID: 32299389
[TBL] [Abstract][Full Text] [Related]
8. Early HIV viral suppression associated with subsequent 12-month treatment success among people living with HIV in South Africa.
Violette LR; Thomas KK; Dorward J; Quame-Amaglo J; Garrett N; Drain PK
HIV Med; 2024 Jun; 25(6):759-765. PubMed ID: 38488308
[TBL] [Abstract][Full Text] [Related]
9. Treatment Outcomes After Switching to Second-Line Anti-Retroviral Therapy: Results From the Thai National Treatment Program.
Sudsila P; Teeraananchai S; Kiertiburanakul S; Lertpiriyasuwat C; Triamwichanon R; Gatechompol S; Putcharoen O; Chetchotisakd P; Avihingsanon A; Kerr SJ; Ruxrungtham K
J Int Assoc Provid AIDS Care; 2023; 22():23259582231220513. PubMed ID: 38115729
[TBL] [Abstract][Full Text] [Related]
10. Early virological response to HIV treatment: can we predict who is likely to experience subsequent treatment failure? Results from an observational cohort study, London, UK.
Brima N; Lampe FC; Copas A; Gilson R; Williams I; Johnson MA; Phillips AN; Smith CJ
J Int AIDS Soc; 2017 Aug; 20(1):21567. PubMed ID: 28853518
[TBL] [Abstract][Full Text] [Related]
11. High levels of viral load monitoring and viral suppression under Treat All in Rwanda - a cross-sectional study.
Ross J; Ribakare M; Remera E; Murenzi G; Munyaneza A; Hoover DR; Shi Q; Nsanzimana S; Yotebieng M; Nash D; Anastos K;
J Int AIDS Soc; 2020 Jun; 23(6):e25543. PubMed ID: 32536033
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy programme outcomes at Senkatana antiretroviral therapy clinic, Lesotho: a four-year retrospective cohort study.
Kabuya M; Musekiwa A; Takuva S; Thabane L; Mbuagbaw L
Pan Afr Med J; 2023; 46():74. PubMed ID: 38282767
[TBL] [Abstract][Full Text] [Related]
13. Retention in Care and Virological Failure among Adult HIV-Positive Patients on First-Line Antiretroviral Treatment in Maputo, Mozambique.
Joaquim L; Miranda MNS; Pimentel V; Martins MDRO; Nhampossa T; Abecasis A; Pingarilho M
Viruses; 2023 Sep; 15(10):. PubMed ID: 37896757
[TBL] [Abstract][Full Text] [Related]
14. Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients.
Häggblom A; Santacatterina M; Neogi U; Gisslen M; Hejdeman B; Flamholc L; Sönnerborg A
PLoS One; 2017; 12(7):e0180140. PubMed ID: 28727795
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland.
Jobanputra K; Parker LA; Azih C; Okello V; Maphalala G; Kershberger B; Khogali M; Lujan J; Antierens A; Teck R; Ellman T; Kosgei R; Reid T
PLoS One; 2015; 10(2):e0116144. PubMed ID: 25695494
[TBL] [Abstract][Full Text] [Related]
16. Rapid Initiation of Antiretroviral Therapy Under the Treat-All Policy Reduces Loss to Follow-Up and Virological Failure in Routine Human Immunodeficiency Virus Care Settings in China: A Retrospective Cohort Study (2016-2022).
Xia H; Li L; Wu Y; Gao L; Zhang D; Ma P
AIDS Patient Care STDS; 2024 Apr; 38(4):168-176. PubMed ID: 38656215
[TBL] [Abstract][Full Text] [Related]
17. Determinants of viral load suppression failure among HIV adults on ARV attending health care facilities: a retrospective study in Tanga region, Tanzania.
Mboggo E; Mtisi E; Mushy SE; Mkawe S; Ngalesoni F; Muya A; Kilimba E; Kamugumya D; Mlay BS
BMC Infect Dis; 2024 Mar; 24(1):312. PubMed ID: 38486174
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes in children and adolescents initiating antiretroviral therapy in decentralized healthcare settings in Zimbabwe.
McHugh G; Simms V; Dauya E; Bandason T; Chonzi P; Metaxa D; Munyati S; Nathoo K; Mujuru H; Kranzer K; Ferrand RA
J Int AIDS Soc; 2017 Sep; 20(1):21843. PubMed ID: 28872269
[TBL] [Abstract][Full Text] [Related]
19. Predictors of first-line antiretroviral therapy failure amongst HIV-infected adult clients at Woldia Hospital, Northeast Ethiopia.
Babo YD; Alemie GA; Fentaye FW
PLoS One; 2017; 12(11):e0187694. PubMed ID: 29095936
[TBL] [Abstract][Full Text] [Related]
20. Reducing time to differentiated service delivery for newly-diagnosed people living with HIV in Kigali, Rwanda: a pilot, unblinded, randomized controlled trial.
Ross J; Anastos K; Hill S; Remera E; Rwibasira GN; Ingabire C; Umwiza F; Munyaneza A; Muhoza B; Zhang C; Nash D; Yotebieng M; Murenzi G
BMC Health Serv Res; 2024 Apr; 24(1):555. PubMed ID: 38693537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
